(1 - 20 von 26
)
Innovationsstandort Basel – Rekordjahr für Firmenansiedlungenwww.bazonline.ch › Basel
www.bazonline.ch
· Martin Heidecker, Chief Investment Officer des AMR Action Fund. «Basel blickt auf eine lange Geschichte biopharmazeutischer Innovationen ...
AMR Action Fund invests in new antibiotics developed by BioVersyswww.s-ge.com › article › news › biotech-bio...
www.s-ge.com
· Martin Heidecker, Chief Investment Officer of the AMR Action Fund, in the press release. “We are eager to work with the BioVersys team to help ...
BioVersys Extends Its Series C Round to CHF Million with ...www.life-sciences-germany.com › news › bioversys...
www.life-sciences-germany.com
· Martin Heidecker, PhD, AMR Action Fund's Chief Investment Officer: “BioVersys is developing antimicrobials that target some of the most ...
The AMR Action Fund Invests In BioVersys In Fight Against Drug ...www.contractpharma.com › view_breaking-news › t...
www.contractpharma.com
· ... and we are thrilled to welcome the company to our portfolio," AMR Action Fund Chief Investment Officer Martin Heidecker, PhD, said.
sortiert nach Relevanz / Datum